A detailed history of Pdt Partners, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 75,144 shares of ARCT stock, worth $1.28 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
75,144
Holding current value
$1.28 Million
% of portfolio
0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.08 - $25.38 $1.36 Million - $1.91 Million
75,144 New
75,144 $1.74 Million
Q2 2022

Aug 15, 2022

BUY
$12.26 - $31.17 $308,167 - $783,489
25,136 Added 50.78%
74,636 $1.18 Million
Q1 2022

May 16, 2022

SELL
$17.64 - $39.57 $62,145 - $139,405
-3,523 Reduced 6.64%
49,500 $1.34 Million
Q4 2021

Feb 14, 2022

BUY
$34.2 - $47.56 $120,486 - $167,553
3,523 Added 7.12%
53,023 $1.96 Million
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $1.38 Million - $2.88 Million
49,500 New
49,500 $2.37 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $452M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.